AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Deep Track Capital acquired a significant stake in Verastem Inc, a biopharmaceutical company developing novel anticancer agents, with a purchase of 7.7 million shares at $7.55 per share. This investment represents a 1.6% impact on Deep Track Capital's portfolio and positions Verastem Inc as a significant holding. Verastem Inc has faced challenges but demonstrated a 25.7% revenue growth over the past three years, with a focus on critical cancer treatment pathways.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet